Predictive value of ¹⁸F-FDG hybrid PET/CT for the clinical outcome in patients with non-Hodgkin's lymphoma prior to and after autologous stem cell transplantation

By Qiao Wenli   Zhao Jinhua   Wang Chun   Wang Taisong   Xing Yan  

Hematology, Vol. 15, Iss. 1, 2010-02 ,pp. : 21-27

Maney Publishing

Access to resources Recommend Favorite

Rituximab plus ASHAP for the treatment of patients with relapsed or refractory aggressive non-Hodgkin’s lymphoma: a single-centre study of 20 patients

By Aydin Semra   Dührsen Ulrich   Nückel Holger  

Annals of Hematology, Vol. 86, Iss. 4, 2007-04 ,pp. : 271-276

Springer Publishing Company

Access to resources Recommend Favorite

The Use of Positron Emission Tomography with [₁₈F] 2-Fluoro-_d-2-Deoxyglucose (FDG-PET) in Hodgkin and Non-Hodgkin's Lymphoma

By Chiusolo Patrizia   Sica Simona   Leone Giuseppe  

Hematology, Vol. 8, Iss. 6, 2003-12 ,pp. : 403-408

Maney Publishing

Access to resources Recommend Favorite

Therapeutic evaluation and prognostic value of interim hybrid PET/CT with ¹⁸F-FDG after three to four cycles of chemotherapy in non-Hodgkin's lymphoma

By Zhao Jinhua   Qiao Wenli   Wang Chun   Wang Taisong   Xing Yan  

Hematology, Vol. 12, Iss. 5, 2007-10 ,pp. : 423-430

Maney Publishing

Access to resources Recommend Favorite

Effect of rituximab on the long-term outcome after high-dose therapy for relapsed B-cell non-Hodgkin’s lymphoma

By Hess Georg   Flohr Thomas   Kolbe Karin   Bonn Sarah   Schuler Martin   Derigs Hans   Huber Christoph  

Annals of Hematology, Vol. 85, Iss. 11, 2006-11 ,pp. : 769-779

Springer Publishing Company

Access to resources Recommend Favorite